Sfoglia per Autore
Alterations of markers related to synaptic function in aging rat brain, in normal conditions or under conditions of long-term dietary manipulation
2004 MONTI B.; VIRGILI M.; CONTESTABILE A.
Disease-related regressive alterations of forebrain cholinergic system in SOD1 mutant transgenic mice
2005 CROCHEMORE C.; PENA-ALTAMIRA E.; VIRGILI M.; MONTI B.; CONTESTABILE A.
Updating the dual role of brain nitric oxide in neurodegeneration/neuroprotection: understanding molecular mechanisms to devise drug approaches.
2005 Contestabile A.; Monti B.; Contestabile A.; Ciani E.
Dysregulation of memory-related proteins in the hippocampus of aged rats and their relation with cognitive impairment.
2005 Monti B.; Berteotti C.; Contestabile A.
Subchronic rolipram delivery activates hippocampal CREB and Arc. enhances retention and slows down extinction of conditioned fear.
2006 Monti B.; Berteotti C:; Contestabile A.
In vitro and in vivo toxicity of type 2 ribosome-inactivating proteins lanceolin and stenodactylin on glial and neuronal cells.
2007 Monti B; D'Alessandro C; Farini V; Bolognesi A; Polazzi E; Contestabile A; Stirpe F; Battelli MG.
Neuroprotezione e meccanismi molecolari delle interazioni tra microglia e neuroni: studio cellulare, funzionale e comportamentale.
2007 B. Monti; M. Caprini; F. Locchi.
Alpha-synuclein protects cerebellar granule neurons against 6-hydroxydopamine-induced death.
2007 Monti B; Polazzi E; Batti L; Crochemore C; Virgili M; Contestabile A.
Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta2
2009 Polazzi, E.; Pena Altamira, L. E.; Eleuteri, S. C.; Barbaro, M. R.; Casadio, C.; Contestabile, A.; Monti, B.
Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection
2009 Monti B.; Polazzi E.; Contestabile A.
Chronic dietary administration of valproic acid protects neurons of the rat nucleus basalis magnocellularis from ibotenic acid neurotoxicity
2009 Eleuteri S.; Monti B.; Brignani S.; Contestabile A.
Memory-enhancing drugs: a molecular perspective
2009 Monti B.; Contestabile A.
Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha synuclein
2010 Monti B.; Gatta V.; Piretti F.; Raffaelli S.; Virgili M.; Contestabile A.
Microglia and neuroprotection: from in vitro studies to therapeutic applications.
2010 Polazzi E.; Monti B.
Valproic acid neuroprotection in 6-OHDAlesioned rat, a model for parkinson's disease
2012 Monti B.; Mercatelli D.; Contestabile A.
Epigenetic mechanisms underlying opiate dependence.
2012 Concas A.; Sassoè-Pognetto M.; Monti B.
Science on both sides of Atlantic (I,II and III)
2012 M.Caprini; M.Cañelles; R.Carbajo; J.Hernandez; B.Monti; J.Neira; C.Nevado; D.Otzen; N.Santos; J.Traverso
Histone Deacetylase (HDAC) Inhibitors as Potential Drugs to Target Memory and Adult Hippocampal Neurogenesis
2012 Contestabile A.; Sintoni S.; Monti B.
Neuronal-glial Interactions Define the Role of Nitric Oxide in Neural Functional Processes
2012 Contestabile A; Monti B; Polazzi E.
Histone post-translational modifications in Huntington's and Parkinson's diseases.
2013 Peña-Altamira LE; Polazzi E; Monti B.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile